Martina Mussi, Corrado Zengarini, Gionathan Orioni, Marco Adriano Chessa, Alessandra Gelmetti, Riccardo Balestri, Michelangelo La Placa, Bianca Maria Piraccini, Iria Neri
{"title":"超越标准:有针对性地重新应用于婴儿掌跖疥疮。","authors":"Martina Mussi, Corrado Zengarini, Gionathan Orioni, Marco Adriano Chessa, Alessandra Gelmetti, Riccardo Balestri, Michelangelo La Placa, Bianca Maria Piraccini, Iria Neri","doi":"10.1093/ced/llaf456","DOIUrl":null,"url":null,"abstract":"<p><p>Infantile scabies can be challenging to treat, particularly due to behavioural and anatomical factors that reduce the efficacy of topical therapies. In this small prospective cohort study there were 22 neonates and infants (11 in either intervention group) with persistent palmar-plantar scabies. Patients were treated exclusively with permethrin 5% cream. All patients initially failed the standard regimen consisting of one full-body application, followed by a second application after 7 days. Eleven infants received an intensified regimen with three additional nights of targeted application to the hands and feet, while eleven continued with the standard regimen only. Complete resolution was observed in all 11 (100%) of cases in the intervention group, compared with none (0%) in the control group. Frequent infant behaviours, including spontaneous kicking, leg movements, and habitual fist clenching, likely reduced drug contact time on palms and soles. These findings indicate that standard topical regimens may be insufficient in this population and that targeted reapplication, combined with caregiver education, can optimize treatment outcomes in infants.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Beyond the Standard: Targeted Reapplication in Palmoplantar Scabies of Infants.\",\"authors\":\"Martina Mussi, Corrado Zengarini, Gionathan Orioni, Marco Adriano Chessa, Alessandra Gelmetti, Riccardo Balestri, Michelangelo La Placa, Bianca Maria Piraccini, Iria Neri\",\"doi\":\"10.1093/ced/llaf456\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Infantile scabies can be challenging to treat, particularly due to behavioural and anatomical factors that reduce the efficacy of topical therapies. In this small prospective cohort study there were 22 neonates and infants (11 in either intervention group) with persistent palmar-plantar scabies. Patients were treated exclusively with permethrin 5% cream. All patients initially failed the standard regimen consisting of one full-body application, followed by a second application after 7 days. Eleven infants received an intensified regimen with three additional nights of targeted application to the hands and feet, while eleven continued with the standard regimen only. Complete resolution was observed in all 11 (100%) of cases in the intervention group, compared with none (0%) in the control group. Frequent infant behaviours, including spontaneous kicking, leg movements, and habitual fist clenching, likely reduced drug contact time on palms and soles. These findings indicate that standard topical regimens may be insufficient in this population and that targeted reapplication, combined with caregiver education, can optimize treatment outcomes in infants.</p>\",\"PeriodicalId\":10324,\"journal\":{\"name\":\"Clinical and Experimental Dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ced/llaf456\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf456","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Beyond the Standard: Targeted Reapplication in Palmoplantar Scabies of Infants.
Infantile scabies can be challenging to treat, particularly due to behavioural and anatomical factors that reduce the efficacy of topical therapies. In this small prospective cohort study there were 22 neonates and infants (11 in either intervention group) with persistent palmar-plantar scabies. Patients were treated exclusively with permethrin 5% cream. All patients initially failed the standard regimen consisting of one full-body application, followed by a second application after 7 days. Eleven infants received an intensified regimen with three additional nights of targeted application to the hands and feet, while eleven continued with the standard regimen only. Complete resolution was observed in all 11 (100%) of cases in the intervention group, compared with none (0%) in the control group. Frequent infant behaviours, including spontaneous kicking, leg movements, and habitual fist clenching, likely reduced drug contact time on palms and soles. These findings indicate that standard topical regimens may be insufficient in this population and that targeted reapplication, combined with caregiver education, can optimize treatment outcomes in infants.
期刊介绍:
Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.